Frontiers in Pharmacology (Jan 2025)

Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems

  • Chengyi He,
  • Yunfei Chen,
  • Jiao Xie,
  • Miao Luo,
  • David Fisher,
  • Nguyen Thi Thu Hien,
  • Erkin Musabaev,
  • Yiping Dang,
  • Lei Zhao,
  • Yin Xia

DOI
https://doi.org/10.3389/fphar.2024.1488003
Journal volume & issue
Vol. 15

Abstract

Read online

Dihydromyricetin (DHM or DMY) is a flavonoid derived from natural sources with a range of confirmed biological benefits. It exhibits anti-inflammatory, antioxidant, anti-tumor, and anti-viral activities. DHM is recognized for its high biosafety, making it a promising subject for further research. This article offers a comprehensive overview of DHM’s pharmacological properties, mechanisms, and recent research developments in the cardiovascular, urinary, digestive, nervous, and respiratory systems. The review summarizes DHM’s biological effects and associated signaling pathways, providing novel insights for its clinical application.

Keywords